BioCentury | Dec 3, 2019
Financial News

Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron

...round raised by the biologics company following its formation in January through the merger of Hangzhou Just Biotherapeutics Ltd....
BioCentury | Apr 6, 2019
Finance

Room to rally in 2Q

...ND NA NA ND Kashiv Pharma LLC Adello Biologics LLC 1/3/19 ND NA NA ND Hangzhou Just Biotherapeutics Ltd....
BioCentury | Apr 5, 2019
Company News

Hangzhou Just licenses Lilly’s bone disease program

...Transcenta Holding’s subsidiary Hangzhou Just Biotherapeutics gained exclusive greater China rights from Lilly to develop and commercialize a...
...also included in the deal. The company did not respond to an inquiry regarding details. Hangzhou Just Biotherapeutics Ltd....
...Transcenta in January (see "Hangzhou Just, MabSpace Merging" ). Hongjiang Li, Staff Writer blosozumab (LY2541546) Eli Lilly and Co. Hangzhou Just Biotherapeutics Ltd. MabSpace...
BioCentury | Mar 12, 2019
Company News

Management tracks: Inovio, Sangamo, Innate

...and head of research. The antibody-based biotherapeutics company formed in January through the merger of Hangzhou Just Biotherapeutics Ltd....
BioCentury | Jan 4, 2019
Company News

Hangzhou Just, MabSpace merging

...Partners and Taikang. Hangzhou Just Biotherapeutics Ltd., Hangzhou, China MabSpace Biosciences Co. Ltd., Hong Kong, China Business: Pharmaceuticals Hongjiang Li MSB2311 Hangzhou Just Biotherapeutics Ltd. MabSpace...
BioCentury | Jan 2, 2019
Company News

Hangzhou Just, MabSpace merging

...including Lilly Asia Ventures, Temasek, Sequoia China, Arch Venture Partners, Teng Yue Partners and Taikang. Hongjiang Li Hangzhou Just Biotherapeutics Ltd. MabSpace...
BioCentury | Jun 8, 2018
Financial News

On verge of global clinical trials, Just China raises $35M

...Biologics company Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) raised $35 million in a series B plus round led by...
...led by Temasek, and has now raised over $120 million. Hangzhou Just Biotherapeutics Ltd., Hangzhou, China Allison Johnson Arch Venture Partners Hangzhou Just Biotherapeutics Ltd. Hillhouse...
BioCentury | Jun 6, 2018
Financial News

Just China raises $35M ahead of global trials

...Biologics company Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) raised $35 million in a series B plus round led by...
...round in August led by Temasek, and has now raised over $120 million. Allison Johnson Arch Venture Partners Hangzhou Just Biotherapeutics Ltd. Hillhouse...
BioCentury | Sep 16, 2017
Finance

Local leverage

...A round, which closed at $15 million in 2015. In 2016, the company’s Chinese affiliate, Hangzhou Just Biotherapeutics Ltd....
...San Francisco, Calif. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Gladstone Institutes, San Francisco, Calif. Hangzhou Just Biotherapeutics Ltd....
BioCentury | Sep 8, 2017
Company News

Lilly revamping presence in China

...on investments in Asia, particularly China. The fund has recently invested in antibody production company Hangzhou Just Biotherapeutics Ltd....
Items per page:
1 - 10 of 14
BioCentury | Dec 3, 2019
Financial News

Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron

...round raised by the biologics company following its formation in January through the merger of Hangzhou Just Biotherapeutics Ltd....
BioCentury | Apr 6, 2019
Finance

Room to rally in 2Q

...ND NA NA ND Kashiv Pharma LLC Adello Biologics LLC 1/3/19 ND NA NA ND Hangzhou Just Biotherapeutics Ltd....
BioCentury | Apr 5, 2019
Company News

Hangzhou Just licenses Lilly’s bone disease program

...Transcenta Holding’s subsidiary Hangzhou Just Biotherapeutics gained exclusive greater China rights from Lilly to develop and commercialize a...
...also included in the deal. The company did not respond to an inquiry regarding details. Hangzhou Just Biotherapeutics Ltd....
...Transcenta in January (see "Hangzhou Just, MabSpace Merging" ). Hongjiang Li, Staff Writer blosozumab (LY2541546) Eli Lilly and Co. Hangzhou Just Biotherapeutics Ltd. MabSpace...
BioCentury | Mar 12, 2019
Company News

Management tracks: Inovio, Sangamo, Innate

...and head of research. The antibody-based biotherapeutics company formed in January through the merger of Hangzhou Just Biotherapeutics Ltd....
BioCentury | Jan 4, 2019
Company News

Hangzhou Just, MabSpace merging

...Partners and Taikang. Hangzhou Just Biotherapeutics Ltd., Hangzhou, China MabSpace Biosciences Co. Ltd., Hong Kong, China Business: Pharmaceuticals Hongjiang Li MSB2311 Hangzhou Just Biotherapeutics Ltd. MabSpace...
BioCentury | Jan 2, 2019
Company News

Hangzhou Just, MabSpace merging

...including Lilly Asia Ventures, Temasek, Sequoia China, Arch Venture Partners, Teng Yue Partners and Taikang. Hongjiang Li Hangzhou Just Biotherapeutics Ltd. MabSpace...
BioCentury | Jun 8, 2018
Financial News

On verge of global clinical trials, Just China raises $35M

...Biologics company Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) raised $35 million in a series B plus round led by...
...led by Temasek, and has now raised over $120 million. Hangzhou Just Biotherapeutics Ltd., Hangzhou, China Allison Johnson Arch Venture Partners Hangzhou Just Biotherapeutics Ltd. Hillhouse...
BioCentury | Jun 6, 2018
Financial News

Just China raises $35M ahead of global trials

...Biologics company Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) raised $35 million in a series B plus round led by...
...round in August led by Temasek, and has now raised over $120 million. Allison Johnson Arch Venture Partners Hangzhou Just Biotherapeutics Ltd. Hillhouse...
BioCentury | Sep 16, 2017
Finance

Local leverage

...A round, which closed at $15 million in 2015. In 2016, the company’s Chinese affiliate, Hangzhou Just Biotherapeutics Ltd....
...San Francisco, Calif. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Gladstone Institutes, San Francisco, Calif. Hangzhou Just Biotherapeutics Ltd....
BioCentury | Sep 8, 2017
Company News

Lilly revamping presence in China

...on investments in Asia, particularly China. The fund has recently invested in antibody production company Hangzhou Just Biotherapeutics Ltd....
Items per page:
1 - 10 of 14